Autonomous Medical Devices Incorporated
AMDI is a California-based company dedicated to developing and manufacturing point-of-care diagnostic devices using innovative technology, microfluidics, protein engineering, and cloud connectivity. Their mission is to create patient-centric, cloud-connected diagnostics that provide actionable information within minutes, with products manufactured in an ISO:13485 certified facility in Santa Ana, CA.
Industries
Nr. of Employees
medium (51-250)
Autonomous Medical Devices Incorporated
Inglewood, California, United States, North America
Products
Ultrafast RT‑PCR point‑of‑care system (intended for CLIA‑waived use)
A compact molecular diagnostic system designed to deliver RT‑PCR results at the time of care in under 10 minutes for multiple respiratory targets; described as intended for CLIA‑waived environments and planned for regulatory submission.
Rapid sample preparation system using hyperbaric heating (RUO)
A research‑use‑only sample‑preparation platform that uses hyperbaric heating to lyse samples and release nucleic acids in under two minutes, intended to remove the need for conventional extraction kits and accelerate molecular workflows.
Quantitative neutralizing antibody IgG assay (RUO)
A research‑use‑only immunochemistry assay for quantifying neutralizing antibody activity and IgG levels; reported to correlate strongly with live‑virus neutralization assays across clinical samples and to provide faster, lower‑cost results compared with live‑virus methods.
Ultrafast RT‑PCR point‑of‑care system (intended for CLIA‑waived use)
A compact molecular diagnostic system designed to deliver RT‑PCR results at the time of care in under 10 minutes for multiple respiratory targets; described as intended for CLIA‑waived environments and planned for regulatory submission.
Rapid sample preparation system using hyperbaric heating (RUO)
A research‑use‑only sample‑preparation platform that uses hyperbaric heating to lyse samples and release nucleic acids in under two minutes, intended to remove the need for conventional extraction kits and accelerate molecular workflows.
Quantitative neutralizing antibody IgG assay (RUO)
A research‑use‑only immunochemistry assay for quantifying neutralizing antibody activity and IgG levels; reported to correlate strongly with live‑virus neutralization assays across clinical samples and to provide faster, lower‑cost results compared with live‑virus methods.
Services
Collaborative R&D partnerships
Opportunities for external collaboration leveraging in‑house expertise in protein engineering, microfluidics, sample prep, assay development, and manufacturing.
Technical documentation and clinical training materials
Provision of clinical quick reference guides and instrument documentation to support clinical implementation and user training.
Participation in government‑funded development projects
Execution and management of federally funded development projects to advance diagnostic systems (example: NIH RADx awards).
Collaborative R&D partnerships
Opportunities for external collaboration leveraging in‑house expertise in protein engineering, microfluidics, sample prep, assay development, and manufacturing.
Technical documentation and clinical training materials
Provision of clinical quick reference guides and instrument documentation to support clinical implementation and user training.
Participation in government‑funded development projects
Execution and management of federally funded development projects to advance diagnostic systems (example: NIH RADx awards).
Expertise Areas
- Point‑of‑care molecular diagnostics
- Multiplex assay development
- Rapid sample preparation technologies
- Clinical study design and multicenter evaluation
Key Technologies
- Ultrafast thermal cycling PCR
- Multiplex RT‑PCR
- Hyperbaric heating sample lysis
- Microfluidics